224 related articles for article (PubMed ID: 16543368)
1. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice.
Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B; McLachlan SM
Endocrinology; 2006 Jun; 147(6):2789-800. PubMed ID: 16543368
[TBL] [Abstract][Full Text] [Related]
2. Shared and unique susceptibility genes in a mouse model of Graves' disease determined in BXH and CXB recombinant inbred mice.
McLachlan SM; Aliesky HA; Pichurin PN; Chen CR; Williams RW; Rapoport B
Endocrinology; 2008 Apr; 149(4):2001-9. PubMed ID: 18162518
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
[TBL] [Abstract][Full Text] [Related]
4. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.
McLachlan SM; Braley-Mullen H; Chen CR; Aliesky H; Pichurin PN; Rapoport B
Endocrinology; 2005 Jan; 146(1):294-300. PubMed ID: 15459116
[TBL] [Abstract][Full Text] [Related]
6. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease.
Chen CR; Pichurin P; Chazenbalk GD; Aliesky H; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Jan; 145(1):228-33. PubMed ID: 14576177
[TBL] [Abstract][Full Text] [Related]
7. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles differ markedly in mouse strains that are (or are not) susceptible to hyperthyroidism induced using thyrotropin receptor-expressing adenovirus.
Chen CR; Abbud R; Wang C; Tan Y; Rapoport B; McLachlan SM
Thyroid; 2005 Nov; 15(11):1229-37. PubMed ID: 16356085
[TBL] [Abstract][Full Text] [Related]
9. A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism.
Nagayama Y; McLachlan SM; Rapoport B; Niwa M
Thyroid; 2003 Mar; 13(3):233-8. PubMed ID: 12729471
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
11. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
Seetharamaiah GS; Land KJ
Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
[TBL] [Abstract][Full Text] [Related]
12. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
13. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.
Misharin A; Hewison M; Chen CR; Lagishetty V; Aliesky HA; Mizutori Y; Rapoport B; McLachlan SM
Endocrinology; 2009 Feb; 150(2):1051-60. PubMed ID: 18927213
[TBL] [Abstract][Full Text] [Related]
15. Genetic linkages for thyroxine released in response to thyrotropin stimulation in three sets of recombinant inbred mice provide evidence for shared and novel genes controlling thyroid function.
Hamidi S; Aliesky HA; Williams RW; Rapoport B; McLachlan SM
Thyroid; 2013 Mar; 23(3):360-70. PubMed ID: 22988948
[TBL] [Abstract][Full Text] [Related]
16. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
[TBL] [Abstract][Full Text] [Related]
17. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
[TBL] [Abstract][Full Text] [Related]
18. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
[TBL] [Abstract][Full Text] [Related]
19. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
Pichurin PN; Chazenbalk GD; Aliesky H; Pichurina O; Rapoport B; McLachlan SM
Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
